Revive Therapeutics Ltd. (RVVTF)
Develops drug treatments for infectious diseases, rare disorders, and mental health conditions
$0.02-0.10%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+28.6%
The outlook
Revive Therapeutics trades near $0.018, sitting in the lower part of its 52-week range. Price action is mixed relative to moving averages, and analyst coverage appears thin. The overall sentiment leans neutral.
What’s behind the score
Price trendMixed vs its moving averages
52-week range28% of the way from its 52-week low to high
Market cap
$7.8M
52-wk high
$0.06
52-wk low
$0.00
50-day avg
$0.02
200-day avg
$0.02
Trailing P/E
—